Blockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT

Cited 30 time in webofscience Cited 0 time in scopus
  • Hit : 1054
  • Download : 1061
DC FieldValueLanguage
dc.contributor.authorLee, Jung-Whoiko
dc.contributor.authorKu, Tae-Yunko
dc.contributor.authorYu, Ha-nako
dc.contributor.authorChong, Kyu-Hako
dc.contributor.authorRyu, Seung-Wookko
dc.contributor.authorChoi, Kyung-Sunko
dc.contributor.authorChoi, Chul-Heeko
dc.date.accessioned2013-03-12T07:42:32Z-
dc.date.available2013-03-12T07:42:32Z-
dc.date.created2012-06-11-
dc.date.created2012-06-11-
dc.date.created2012-06-11-
dc.date.created2012-06-11-
dc.date.issued2012-05-
dc.identifier.citationCANCER LETTERS, v.318, no.2, pp.221 - 225-
dc.identifier.issn0304-3835-
dc.identifier.urihttp://hdl.handle.net/10203/101682-
dc.description.abstractBlockade of VEGF signaling using RNA interferences, a neutralizing antibody, an antagonizing soluble VEGF receptor, and a receptor tyrosine kinase inhibitor induced anti-tumor effects in human astrocytoma U251-MG and fibrosarcoma HT-1080 in vitro in a dose-dependent manner. Furthermore, blockade of VEGF-A using the doxycycline-inducible VEGF-A RNA interference system showed a significant antitumor effect in a murine HT-1080-xenograft model. Anti-tumor effect through the blockade of VEGF signaling was mediated by FAK and AKT pathway in vitro and in vivo. These results collectively indicate that VEGF-A and its receptors can act as key inducer of tumor growth as well as angiogenesis. (C) 2011 Elsevier Ireland Ltd. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER IRELAND LTD-
dc.titleBlockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT-
dc.typeArticle-
dc.identifier.wosid000302430000013-
dc.identifier.scopusid2-s2.0-84858158912-
dc.type.rimsART-
dc.citation.volume318-
dc.citation.issue2-
dc.citation.beginningpage221-
dc.citation.endingpage225-
dc.citation.publicationnameCANCER LETTERS-
dc.identifier.doi10.1016/j.canlet.2011.12.014-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.contributor.localauthorKu, Tae-Yun-
dc.contributor.localauthorChoi, Chul-Hee-
dc.description.isOpenAccessN-
dc.type.journalArticleArticle-
dc.subject.keywordAuthorVEGF-
dc.subject.keywordAuthorFAK-
dc.subject.keywordAuthorAKT-
dc.subject.keywordAuthorApoptosis-
dc.subject.keywordAuthorAutocrine signaling-
dc.subject.keywordPlusANGIOGENESIS-
dc.subject.keywordPlusCANCER-
dc.subject.keywordPlusDISEASES-
dc.subject.keywordPlusKINASE-
dc.subject.keywordPlusCELLS-
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 30 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0